Research and Development

Showing 15 posts of 9616 posts found.

mylan

Mylan pays $96.5 million to settle pay-for-delay case

February 7, 2017 Research and Development, Sales and Marketing Cephalon, Mylan, Teva, antitrust

Mylan has agreed to pay $96.5 million in order to settle an antitrust case. The case was related to the …
mosquito

Abbott’s Zika virus test given FDA authorisation

February 7, 2017 Manufacturing and Production, Research and Development Abbott Laboratories, Zika virus

The threat of the Zika virus, though it may have disappeared from the headlines, is still very much present. Any …
hugo_fry

Sanofi reinforces senior staff with two new execs

February 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi

Sanofi has reinforced its senior staff with a double-whammy of appointments; firstly, the French firm has announced that it is …
ken_cunningham

Medherant appoints new Chairman

February 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medherant

Medherant has brought in Dr Ken Cunningham as Chair in a bid to strengthen the company as it moves into …
social_media

Socially vigilant: Does pharmacovigilance need secondary data & social media?

February 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, pharmacovigilance

As the world’s drug consumption continues to rise alongside advancements in the medical and pharmaceutical industries, so too do new …
dna_research

Link discovered between immune system genes and leukaemia

February 6, 2017 Research and Development, Sales and Marketing Bloodwise, ICR, leukaemia

Research coming out of The Institute of Cancer Research, and funded by charity Bloodwise, has found that people who inherit …
innate-pharma

Phase 2 failure for Innate Pharma leukaemia drug

February 6, 2017 Research and Development, Sales and Marketing Innate Pharma, leukaemia, lirilumab

Lirilumab, Innate Pharma’s acute myeloid leukaemia (AML) treatment, has failed to meet its primary end point in a recent Phase …
cancer-389921_960_720

Cancer rates set to rocket in women six times faster than men

February 3, 2017 Medical Communications, Research and Development Cancer, Cancer Research UK, World Cancer Day

The figures emerging from research conducted by Cancer Research UK predict that rates of cancer in women will rise by …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Moving into February,and the first weeks of Trump’s term, the US President has dominated the headlines in the industry as …
pills

Study reveals antidepressant medication’s action upon brain

February 3, 2017 Medical Communications, Research and Development antidepressants, mental health, research

With levels of antidepressant prescription rising coupled with the lack of development and investment in new treatments, further research into …

Cirrus ready for serialisation pack changes

February 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cirrus, Multi Packaging Solutions

Cirrus, a Multi Packaging Solutions company, offers a full artwork management service ahead of enforced pack changes due to impending …
heart_rope

More at risk of sudden death due to faulty heart gene than thought

February 2, 2017 Medical Communications, Research and Development British Heart Foundation, faulty gene, sudden death

The British Heart Foundation has revealed that around 620,000 people are thought to be at risk of having a faulty …
insider_interview_headshots_2016_overview

2016: A retrospective from the industry

February 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

2016 was characterised by some of the biggest political shifts in recent times. We ask four major pharma figures for …
syringe-1973129_960_720

‘Last-resort’ antibiotic-resistant bacteria found along 4km of Chinese coastline

February 2, 2017 Medical Communications, Research and Development

Recent research has been published that reveals that a four kilometre stretch of coastline in China harboured bacteria resistant to …

Two-decade-long prostate cancer study finds antiandrogen improves survival

February 2, 2017 Research and Development antiandrogen, oncology, prostate cancer

Research conducted over the course of two decades has found a positive correlation between overall survival in prostate cancer patients …
The Gateway to Local Adoption Series

Latest content